PCOS (Polycystic Ovary Syndrome) How its suspected to work: - Reduces insulin resistance (a key driver of PCOS) - Promotes weight loss, which improves hormone balance - May lower testosterone and help regulate cycles - Reduces inflammation, which worsens symptoms Fatty Liver Disease (NAFLD/NASH) - Reduces liver fat by improving insulin sensitivity - Lowers inflammation and oxidative stress in liver cells - Helps with weight loss, which improves liver function Some GLP-1s are currently in trials for direct liver health benefits
Fort, MSN, AGACNP-BC Discover more events from LaTeisha N
The MAXXING Glow Serum is built for this entry-point role
Ideally wed cut our body fat while maintaining or building our muscle
GLP-1 RAs STEP 1 (2021) : Semaglutide 2.4 ./ 14.9% 68 2.4% (Wilding et al., 2021, NEJM) SURMOUNT-1 (2022) : Tirzepatide (GLP-1/GIP dual agonist) 15 ./ 20.9% (Jastreboff et al., 2022, NEJM) GLP-1 HbA1c () 2 (Hypoglycemia) Glucose-dependent LEADER (liraglutide) SUSTAIN-6 (semaglutide) 2024 FDA Semaglutide (Wegovy) FLOW (2024) semaglutide (MASLD/NAFLD) GLP-1 RAs GLP-1
It depends on drug and plan tier